Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer.

Lee JM, Hays JL, Chiou VL, Annunziata CM, Swisher EM, Harrell MI, Yu M, Gordon N, Sissung TM, Ji J, Figg WD, Minasian L, Lipkowitz S, Wood BJ, Doroshow J, Kohn EC.

Oncotarget. 2017 Mar 25;8(45):79175-79187. doi: 10.18632/oncotarget.16577. eCollection 2017 Oct 3.

2.

Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer.

Lee JM, Peer CJ, Yu M, Amable L, Gordon N, Annunziata CM, Houston N, Goey AK, Sissung TM, Parker B, Minasian L, Chiou VL, Murphy RF, Widemann BC, Figg WD, Kohn EC.

Clin Cancer Res. 2017 Mar 15;23(6):1397-1406. doi: 10.1158/1078-0432.CCR-16-1546. Epub 2016 Sep 23.

3.

Reply to A. Wong et al.

Chiou VL, Burotto M.

J Clin Oncol. 2016 May 1;34(13):1562-3. doi: 10.1200/JCO.2015.66.2031. Epub 2016 Feb 29. No abstract available.

4.

Pseudoprogression and Immune-Related Response in Solid Tumors.

Chiou VL, Burotto M.

J Clin Oncol. 2015 Nov 1;33(31):3541-3. doi: 10.1200/JCO.2015.61.6870. Epub 2015 Aug 10. No abstract available.

5.

The MAPK pathway across different malignancies: a new perspective.

Burotto M, Chiou VL, Lee JM, Kohn EC.

Cancer. 2014 Nov 15;120(22):3446-56. doi: 10.1002/cncr.28864. Epub 2014 Jun 19. Review.

6.

Profile of minocycline neuroprotection in bilirubin-induced auditory system dysfunction.

Rice AC, Chiou VL, Zuckoff SB, Shapiro SM.

Brain Res. 2011 Jan 12;1368:290-8. doi: 10.1016/j.brainres.2010.10.052. Epub 2010 Nov 12.

Supplemental Content

Loading ...
Support Center